Skip to main content
. 2021 Mar 23;10:e64356. doi: 10.7554/eLife.64356

Figure 6. Percentage contributions of different tissues to plasma DNA with tumor-specific and wildtype alleles in two hepatocellular cancer (HCC) patients.

Figure 6.

The tumor-specific mutations were deduced directly from the plasma.